Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Immunotherapy in dMMR/MSI-H recurrent/metastatic endometrial cancer: Monotherapy or combination?

Presentation by Expert 

Date

21 Oct 2023

Session

Immunotherapy in dMMR/MSI-H recurrent/metastatic endometrial cancer: Monotherapy or combination?

Topics

Immunotherapy

Tumour Site

Endometrial Cancer

Presenters

Susana Banerjee

Authors

S. Banerjee

Author affiliations

  • Gynaecology Department, The Royal Marsden Hospital - Chelsea, SW3 6JJ - London/GB

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.